Login / Signup

A New Strategy for Adult T-Cell Leukemia Treatment Targeting Glycogen Synthase Kinase-3β.

Chie IshikawaNaoki Mori
Published in: European journal of haematology (2024)
GSK-3β functions as an oncogene in ATL and could be a potential therapeutic target.
Keyphrases
  • acute myeloid leukemia
  • bone marrow
  • signaling pathway
  • cancer therapy
  • pi k akt
  • protein kinase
  • tyrosine kinase
  • risk assessment
  • climate change
  • young adults
  • human health